Executive Director, Pharmacometrics US
Astellas Pharma Inc.
Stacey Tannenbaum is an Executive Director, leading the US Pharmacometrics group at Astellas Pharma. Stacey completed her BSE in Biomedical Engineering at Duke University, and her PhD in Pharmaceutical Sciences and Applied Mathematics at the University of Arizona. She held a post-doctoral fellowship at the Center for Drug Development Science at Georgetown University. Stacey spent 8.5 years in the Modeling and Simulation (M&S) group at Novartis then joined Astellas in January of 2012. She holds faculty positions at the University of Arizona, University of the Pacific, and the University of Tennessee Health Science Center.
Stacey has had significant impact on the global Pharmacometrics community by co-founding the International Society of Pharmacometrics (ISoP), serving as its first President, and sits on a number of ISoP committees and interest groups including chairing the Statistics and Pharmacometrics Special Interest Group. She also co-founded the American Conference on Pharmacometrics (ACoP) and was conference chair for the first three events. She received the ISoP Fellowship in 2014 and Leadership Award in 2018. Stacey co-founded the local networking group Modeling and Simulation Applications in Clinical Pharmacotherapy (MoSAiC) and is the Executive Committee chair for the World Conference on Pharmacometrics (WCoP). She served as a board member of the American Association of Pharmaceutical Scientists (AAPS), chaired the AAPS M&S Focus Group, and was the co-chair for the AAPS Forum for Connecting Predictive Modelers. She served on the ASCPT Nominations Committee for 2021.
Disclosure information not submitted.
Wednesday, March 16, 2022
12:00 PM – 1:00 PM ET
Friday, March 18, 2022
2:30 PM – 3:30 PM ET
.png)